| Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database AJ Tyndall, B Bannert, M Vonk, P Airò, F Cozzi, PE Carreira, DF Bancel, ... Annals of the rheumatic diseases 69 (10), 1809-1815, 2010 | 1515 | 2010 |
| Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database UA Walker, A Tyndall, L Czirják, CP Denton, D Farge-Bancel, ... Annals of the rheumatic diseases 66 (6), 754-763, 2007 | 1115 | 2007 |
| Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer: a randomized controlled study G Meyer, Z Marjanovic, J Valcke, B Lorcerie, Y Gruel, P Solal-Celigny, ... Archives of internal medicine 162 (15), 1729-1735, 2002 | 1062 | 2002 |
| EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR) O Kowal-Bielecka, R Landewé, J Avouac, S Chwiesko, I Miniati, L Czirjak, ... Annals of the rheumatic diseases 68 (5), 620-628, 2009 | 892 | 2009 |
| Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial JM Van Laar, D Farge, JK Sont, K Naraghi, Z Marjanovic, J Larghero, ... Jama 311 (24), 2490-2498, 2014 | 752 | 2014 |
| International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer D Farge, P Debourdeau, M Beckers, C Baglin, RM Bauersachs, B Brenner, ... Journal of Thrombosis and Haemostasis 11 (1), 56-70, 2013 | 688 | 2013 |
| Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually JR Passweg, H Baldomero, P Bader, C Bonini, S Cesaro, P Dreger, ... Bone marrow transplantation 51 (6), 786-792, 2016 | 560 | 2016 |
| Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases JE Gottenberg, L Guillevin, O Lambotte, B Combe, Y Allanore, ... Annals of the rheumatic diseases 64 (6), 913-920, 2005 | 511 | 2005 |
| Indications for allo-and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015 A Sureda, P Bader, S Cesaro, P Dreger, RF Duarte, C Dufour, ... Bone marrow transplantation 50 (8), 1037-1056, 2015 | 470 | 2015 |
| 2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer D Farge, C Frere, JM Connors, C Ay, AA Khorana, A Munoz, B Brenner, ... The Lancet Oncology 20 (10), e566-e581, 2019 | 455 | 2019 |
| Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years’ experience from the European Group for Blood and Marrow … D Farge, M Labopin, A Tyndall, A Fassas, GL Mancardi, J Van Laar, ... haematologica 95 (2), 284, 2010 | 452 | 2010 |
| Diagnosis and management of acute deep vein thrombosis: a joint consensus document from the European Society of Cardiology working groups of aorta and peripheral vascular … L Mazzolai, V Aboyans, W Ageno, G Agnelli, A Alatri, R Bauersachs, ... European heart journal 39 (47), 4208-4218, 2018 | 442 | 2018 |
| International clinical practice guidelines including guidance for direct oral anticoagulants in the treatment and prophylaxis of venous thromboembolism in patients with cancer D Farge, H Bounameaux, B Brenner, F Cajfinger, P Debourdeau, ... The Lancet Oncology 17 (10), e452-e466, 2016 | 416 | 2016 |
| International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer P Debourdeau, D Farge, M Beckers, C Baglin, RM Bauersachs, B Brenner, ... Journal of Thrombosis and Haemostasis 11 (1), 71-80, 2013 | 373 | 2013 |
| Autologous stem cell transplantation for systemic lupus erythematosus D Jayne, A Tyndall Lupus 13 (5), 359-365, 2004 | 353 | 2004 |
| Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease M Binks, JR Passweg, D Furst, P McSweeney, K Sullivan, C Besenthal, ... Annals of the rheumatic diseases 60 (6), 577-584, 2001 | 351 | 2001 |
| Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation JA Snowden, R Saccardi, M Allez, S Ardizzone, R Arnold, R Cervera, ... Bone marrow transplantation 47 (6), 770-790, 2012 | 342 | 2012 |
| Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT/EULAR Registry D Farge, J Passweg, JM Van Laar, Z Marjanovic, C Besenthal, J Finke, ... Annals of the rheumatic diseases 63 (8), 974-981, 2004 | 314 | 2004 |
| Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of patients with systemic sclerosis Y Allanore, C Meune, MC Vonk, P Airo, E Hachulla, P Caramaschi, ... Annals of the rheumatic diseases 69 (01), 218-221, 2010 | 309 | 2010 |
| Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants JR Passweg, H Baldomero, P Bader, C Bonini, S Cesaro, P Dreger, ... Bone marrow transplantation 50 (4), 476-482, 2015 | 291 | 2015 |
